Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Canada Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20017
20031
20042
20053
20069
20072
20082
20094
20107
20119
20123
20134
20145
20155
20167
20178
20184
20192
20201
20213
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto8
AstraZeneca5
National Cancer Institute (NCI)5
Pfizer5
Celgene4
Novartis Pharmaceuticals4
Alliance for Clinical Trials in Oncology3
Eli Lilly and Company3
NCIC Clinical Trials Group3
Bristol-Myers Squibb2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms96
Neoplasms15
Colorectal Neoplasms13
Breast Neoplasms11
Ovarian Neoplasms11
Triple Negative Breast Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms6
Pancreatic Diseases6
Prostatic Neoplasms6

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.